Patents by Inventor Daniele D'Ambrosio

Daniele D'Ambrosio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies and derivatives thereof
    Patent number: 9751947
    Abstract: An anti-TrkA antibody is provided that comprises: a) a variable heavy chain comprising a sequence selected from any of BXhVH1, BXhVH2, BXhVH3, BXhVH4, BXhVH5, or HuVHWOv as shown in FIG. 1a; or from variants of any of said sequences and/or b) a variable light chain comprising a sequence selected from any of BXhVL1, BXhVL2, BXhVL3, BXhVL4, BXhVL5, BXhVL6, BXhVL7 or BXhVL8; as shown in FIG. 1b, or from variants of any of said sequences. TrkA-binding derivatives are also provided. Antibodies or derivatives of the present invention are useful in a number of therapies, including pain therapy.
    Type: Grant
    Filed: February 4, 2009
    Date of Patent: September 5, 2017
    Assignee: LAY LINE GENOMICS S.P.A.
    Inventors: Fabio Benigni, Daniele D'Ambrosio
  • System for satellite communications in tunnels
    Patent number: 8837333
    Abstract: The present invention relates to a satellite communication system for extending communications between a vehicle and a satellite in an area of non-visibility of the satellite. The satellite communication system comprises a fixed transceiver system and a mobile transceiver system. The fixed transceiver system includes a first antenna intended to be positioned outside the area of non-visibility of the satellite, and at least one second antenna coupled with the first antenna and intended to be positioned in the area of non-visibility of the satellite. The fixed transceiver system is configured to receive through the first antenna downlink signals transmitted by the satellite on at least one downlink carrier frequency and to transmit the received downlink signals on the at least one downlink carrier frequency in the area of non-visibility of the satellite through the at least one second antenna.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: September 16, 2014
    Assignee: Telespazio S.p.A.
    Inventors: Antonio Saitto, Damiano De Luca, Rosario Bono, Daniele D'Ambrosio
  • System for Satellite Communications in Tunnels
    Publication number: 20120069777
    Abstract: The present invention relates to a satellite communication system for extending communications between a vehicle and a satellite in an area of non-visibility of the satellite. The satellite communication system comprises a fixed transceiver system and a mobile transceiver system. The fixed transceiver system includes a first antenna intended to be positioned outside the area of non-visibility of the satellite, and at least one second antenna coupled with the first antenna and intended to be positioned in the area of non-visibility of the satellite. The fixed transceiver system is configured to receive through the first antenna downlink signals transmitted by the satellite on at least one downlink carrier frequency and to transmit the received downlink signals on the at least one downlink carrier frequency in the area of non-visibility of the satellite through the at least one second antenna.
    Type: Application
    Filed: December 18, 2009
    Publication date: March 22, 2012
    Applicant: TELESPAZIO S.P.A.
    Inventors: Antonio Saitto, Damiano De Luca, Rosario Bono, Daniele D'Ambrosio
  • ANTIBODIES AND DERIVATIVES THEREOF
    Publication number: 20110145941
    Abstract: An anti-TrkA antibody is provided that comprises: a) a variable heavy chain comprising a sequence selected from any of BXhVH1, BXhVH2, BXhVH3, BXhVH4, BXhVH5, or HuVHWOv as shown in FIG. 1a; or from variants of any of said sequences and/or b) a variable light chain comprising a sequence selected from any of BXhVL1, BXhVL2, BXhVL3, BXhVL4, BXhVL5, BXhVL6, BXhVL7 or BXhVL8; as shown in FIG. 1b, or from variants of any of said sequences. TrkA-binding derivatives are also provided. Antibodies or derivatives of the present invention are useful in a number of therapies, including pain therapy.
    Type: Application
    Filed: February 4, 2009
    Publication date: June 16, 2011
    Applicant: LAY LINE GENOMICS S.P.A.
    Inventors: Fabio Benigni, Daniele D'Ambrosio